金刚烷胺治疗期间出现网状青斑。
Livedo reticularis during amantadine treatment.
作者信息
Vollum D I, Parkes J D, Doyle D
出版信息
Br Med J. 1971 Jun 12;2(5762):627-8. doi: 10.1136/bmj.2.5762.627.
Abstract
Livedo reticularis is a common side effect of treatment with amantadine for Parkinson's disease. Investigation of 40 such patients suggests that the livedo is a physiological response provoked by depletion of catecholamine stores in peripheral nerve terminals.
摘要
网状青斑是金刚烷胺治疗帕金森病的常见副作用。对40例此类患者的调查表明，网状青斑是由外周神经末梢儿茶酚胺储备耗竭引发的一种生理反应。
相似文献
1
Livedo reticularis during amantadine treatment.金刚烷胺治疗期间出现网状青斑。
Br Med J. 1971 Jun 12;2(5762):627-8. doi: 10.1136/bmj.2.5762.627.
2
Livedo reticularis in Parkinson's disease patients treated with amantadine hydrochloride.盐酸金刚烷胺治疗帕金森病患者时出现的网状青斑
Neurology. 1972 Jul;22(7):665-9. doi: 10.1212/wnl.22.7.665.
3
Amantadine-induced livedo reticularis--Case report.金刚烷胺诱发的网状青斑——病例报告。
An Bras Dermatol. 2015 Sep-Oct;90(5):745-7. doi: 10.1590/abd1806-4841.20153394.
4
[Amantadine-induced livedo reticularis].[金刚烷胺诱发的网状青斑]
Hautarzt. 1998 Mar;49(3):224-7. doi: 10.1007/s001050050732.
5
Amantadine-induced livedo reticularis: a report of two cases.金刚烷胺诱发的网状青斑：两例报告。
J Drugs Dermatol. 2006 Mar;5(3):288-9.
6
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.金刚乙胺用于对金刚烷胺产生外周不良反应的帕金森病患者：病例系列报告
Mov Disord. 2005 Jul;20(7):873-7. doi: 10.1002/mds.20471.
7
[Reticular livedo due to amantadine].[金刚烷胺所致网状青斑]
Bull Soc Fr Dermatol Syphiligr. 1971;78(3):236-7.
8
Amantadine-Induced Livedo Racemosa.金刚烷胺诱发的双侧性网状青斑
Int J Low Extrem Wounds. 2016 Mar;15(1):78-81. doi: 10.1177/1534734615603566. Epub 2015 Sep 3.
9
Case for diagnosis.诊断病例
An Bras Dermatol. 2012 Mar-Apr;87(2):319-21. doi: 10.1590/s0365-05962012000200025.
10
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study.金刚烷胺与左旋多巴治疗帕金森病：一项为期一年的研究。
Lancet. 1971 May 29;1(7709):1083-6. doi: 10.1016/s0140-6736(71)91834-4.
引用本文的文献
1
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.奥匹卡朋，一种新型儿茶酚-O-甲基转移酶抑制剂，用于治疗帕金森病的“关”期发作。
Health Psychol Res. 2022 Jun 28;10(3):36074. doi: 10.52965/001c.36074. eCollection 2022.
2
Covalent cucurbit[7]uril-dye conjugates for sensing in aqueous saline media and biofluids.用于在盐水介质和生物流体中进行传感的共价葫芦[7]脲-染料共轭物。
Chem Sci. 2020 Sep 22;11(41):11142-11153. doi: 10.1039/d0sc03079a.
3
Cutaneous Adverse Effects of Neurologic Medications.神经科药物的皮肤不良反应
CNS Drugs. 2016 Mar;30(3):245-67. doi: 10.1007/s40263-016-0318-7.
4
Amantadine-induced livedo reticularis--Case report.金刚烷胺诱发的网状青斑——病例报告。
An Bras Dermatol. 2015 Sep-Oct;90(5):745-7. doi: 10.1590/abd1806-4841.20153394.
5
Livedo reticularis and related disorders.网状青斑及相关疾病
Curr Treat Options Cardiovasc Med. 2011 Apr;13(2):179-91. doi: 10.1007/s11936-011-0115-z.
6
The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.患有网状青斑和匐行性血管瘤的神经科患者的鉴别诊断范围。文献综述。
J Neurol. 2005 Oct;252(10):1155-66. doi: 10.1007/s00415-005-0967-9. Epub 2005 Aug 26.
7
Anti-parkinsonian drugs today.当今的抗帕金森病药物。
Drugs. 1984 Sep;28(3):236-62. doi: 10.2165/00003495-198428030-00002.
本文引用的文献
1
Livedo reticularis in patients with parkinsonism receiving amantadine.接受金刚烷胺治疗的帕金森病患者出现网状青斑。
JAMA. 1970 Jun 1;212(9):1522-3.
2
Amantadine-dopamine interaction: possible mode of action in Parkinsonism.金刚烷胺 - 多巴胺相互作用：帕金森病可能的作用模式。
Science. 1970 Jul 10;169(3941):203-4. doi: 10.1126/science.169.3941.203.
Zotero 插件